| Stereochemistry | RACEMIC |
| Molecular Formula | C22H18ClF2N3O4 |
| Molecular Weight | 461.846 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC(F)(C(=O)NCC1=CC=C2C(=O)N(CC2=C1)C3CCC(=O)NC3=O)C4=CC=C(Cl)C=C4
InChI
InChIKey=PWBHUSLMHZLGRN-UHFFFAOYSA-N
InChI=1S/C22H18ClF2N3O4/c23-15-4-2-14(3-5-15)22(24,25)21(32)26-10-12-1-6-16-13(9-12)11-28(20(16)31)17-7-8-18(29)27-19(17)30/h1-6,9,17H,7-8,10-11H2,(H,26,32)(H,27,29,30)
| Molecular Formula | C22H18ClF2N3O4 |
| Molecular Weight | 461.846 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG | 808421 |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
11261 | PRIMARY | |||
|
R76M2Z6366 | PRIMARY | |||
|
C131177 | PRIMARY | |||
|
118647211 | PRIMARY | |||
|
1860875-51-9 | PRIMARY | |||
|
300000028075 | PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
